+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of 13 patients with vasculitis and other autoimmune diseases with intravenous immunoglobulin



Treatment of 13 patients with vasculitis and other autoimmune diseases with intravenous immunoglobulin



Clinical & Experimental Immunology 120(Suppl 1): 12-13




(PDF emailed within 1 workday: $29.90)

Accession: 035980305

Download citation: RISBibTeXText


Related references

Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune diseases with intravenous immunoglobulin. Clinical & Experimental Immunology 120(Suppl 1): 73, 2000

Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin. International Archives of Allergy and Immunology 119(3): 231-238, 1999

Intravenous immunoglobulin treatment in autoimmune diseases. Recenti Progressi in Medicina 98(6): 322-326, 2007

Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin. Clinical and Experimental Immunology 97 Suppl 1: 31-38, 1994

Autoimmune diseases, IgA deficiency, and intravenous immunoglobulin treatment. American Journal of Medicine 93(1): 114-115, 1992

Intravenous immunoglobulin treatment of neurological autoimmune diseases. Journal Of The Neurological Sciences. 153(2): 203-214,. 8, 1998

Analysis of thromboembolic risk related to high-dose intravenous immunoglobulin treatment: a preliminary clinical study of 10 patients with autoimmune mucocutaneous blistering diseases. Clinical and Experimental Dermatology 34(2): 145-150, 2009

Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 115(8): 83-93, 2015

Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases. Clinical and Experimental Rheumatology 11 Suppl 9: S33-S36, 1993

Intravenous immunoglobulin: recent advances in the treatment of autoimmune bullous diseases. Giornale Italiano di Dermatologia E Venereologia 147(3): 259-267, 2012

Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy. Expert Opinion on Investigational Drugs 13(8): 1019-1032, 2004

The steroid-sparing effect of intravenous immunoglobulin in patients with autoimmune diseases. Expert Review of Clinical Immunology 3(5): 773-780, 2007

Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases. Pharmacology 62(3): 133-137, 2001

Long-term therapy with intravenous immunoglobulin is beneficial in patients with autoimmune diseases. Clinical Reviews in Allergy & Immunology 42(2): 247-255, 2012

Intravenous immunoglobulin application following immunoadsorption Benefit or risk in patients with autoimmune diseases?. Kidney & Blood Pressure Research 23(3-5): 303, 2000